Joshy George

2005–2025 年に発表

73
論文数
18,250
被引用数
54
h 指数
67
i10 指数

被引用数

Joshy George の年別被引用数1988 年: 被引用 1 件1989 年: 被引用 1 件1993 年: 被引用 1 件1998 年: 被引用 1 件2003 年: 被引用 1 件2005 年: 被引用 1 件2006 年: 被引用 39 件2007 年: 被引用 120 件2008 年: 被引用 221 件2009 年: 被引用 256 件2010 年: 被引用 254 件2011 年: 被引用 236 件2012 年: 被引用 217 件2013 年: 被引用 241 件2014 年: 被引用 223 件2015 年: 被引用 232 件2016 年: 被引用 273 件2017 年: 被引用 280 件2018 年: 被引用 271 件2019 年: 被引用 675 件2020 年: 被引用 762 件2021 年: 被引用 705 件2022 年: 被引用 566 件2023 年: 被引用 454 件2024 年: 被引用 658 件2025 年: 被引用 298 件2026 年: 被引用 16 件1990〜1992 年は被引用が無いため表示していません1994〜1997 年は被引用が無いため表示していません1999〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,729 件、この内訳の 26.7%中国: 引用元論文 1,144 件、この内訳の 11.2%イギリス: 引用元論文 792 件、この内訳の 7.7%カナダ: 引用元論文 476 件、この内訳の 4.6%ドイツ: 引用元論文 438 件、この内訳の 4.3%オーストラリア: 引用元論文 427 件、この内訳の 4.2%イタリア: 引用元論文 399 件、この内訳の 3.9%日本: 引用元論文 296 件、この内訳の 2.9%フランス: 引用元論文 293 件、この内訳の 2.9%シンガポール: 引用元論文 222 件、この内訳の 2.2%オランダ: 引用元論文 216 件、この内訳の 2.1%スペイン: 引用元論文 215 件、この内訳の 2.1%
0%26.7%その他 25.2%

分野

  • Biochemistry, Genetics and Molecular Biology52%
  • Medicine36.1%
  • Immunology and Microbiology4.7%
  • Environmental Science2.3%
  • Computer Science1.5%
  • Neuroscience0.8%
  • その他2.6%

トピック

  • Ovarian cancer diagnosis and treatment5.1%
  • PARP inhibition in cancer therapy3%
  • Epigenetics and DNA Methylation2.9%
  • Pluripotent Stem Cells Research2.8%
  • Cancer Genomics and Diagnostics2.8%
  • CRISPR and Genetic Engineering2.5%
  • その他80.9%

共著者

全論文

検索で開く
  1. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 459

  2. Whole–genome characterization of chemoresistant ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patricia O’Brien, Jodie Leditschke, Greg Young, Kate Strachan, Paul Waring, Walid J. Azar, Thomas J. Mitchell, Nadia Traficante, Joy Hendley, Heather Thorne, Mark Shackleton, David K. Miller, Gisela Mir Arnau, Richard W. Tothill, Timothy P. Holloway, Timothy Semple, Ivon Harliwong, Craig Nourse, Ehsan Nourbakhsh, Suzanne Manning, Senel Idrisoglu, Timothy J. C. Bruxner, Angelika N. Christ, Barsha Poudel, Oliver Holmes, Matthew J. Anderson, Conrad Leonard, Andrew Lonie, Nathan E. Hall, Scott Wood, Darrin F. Taylor, Qinying Xu, J. Lynn Fink, Nick M. Waddell, Ronny Drapkin, Euan A. Stronach, Hani Gabra, Robert Brown, Andrea Jewell, Shivashankar H. Nagaraj, Emma Markham, Peter J. Wilson, Jason Ellul, Orla McNally, Maria Doyle, Ravikiran Vedururu, Collin Stewart, Ernst Lengyel, John V. Pearson, Nicola Waddell, Anna DeFazio, Sean M. Grimmond, David D.L. Bowtell - Nature 2015 被引用: 1,658

  3. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes

    著者: , , , , , , , , - Genome Research 2016 被引用: 638

  4. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2008 被引用: 1,511

  5. Poison Exon Splicing Regulates a Coordinated Network of SR Protein Expression during Differentiation and Tumorigenesis

    著者: , , , , , , , , , , - Molecular Cell 2020 被引用: 162

  6. BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

    著者: , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 1,176

  7. Harnessing large language models (LLMs) for candidate gene prioritization and selection

    著者: , , , , , , , , , , , , - Journal of Translational Medicine 2023 被引用: 64

  8. The chromatin accessibility signature of human immune aging stems from CD8+ T cells

    著者: , , , , , , , , , , , - The Journal of Experimental Medicine 2017 被引用: 208

  9. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2006 被引用: 2,456

  10. CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer

    著者: , , , , , , , , , , , , , , - Cancer Research 2015 被引用: 260

  11. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

    著者: , , , , , , , , , , , , , , , , - EBioMedicine 2020 被引用: 135

  12. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2014 被引用: 300

  13. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Vierkant, Julie M. Cunningham, Louise A. Brinton, Hannah Yang, Mark E. Sherman, Montserrat García‐Closas, Jolanta Lissowska, Kunle Odunsi, Carl Morrison, Shashikant Lele, Wiam Bshara, Lara Sucheston, Mercedes Jimenez‐Liñan, Kristy Driver, Jennifer Alsop, Marie Mack, Valerie McGuire, Joseph H. Rothstein, Barry P. Rosen, Marcus Q. Bernardini, Helen Mackay, Amit M. Oza, Eva Wozniak, Elizabeth Benjamin, Aleksandra Gentry‐Maharaj, Simon A. Gayther, Anna V. Tinker, Leah Prentice, Christine Chow, Michael S. Anglesio, Sharon E. Johnatty, Georgia Chenevix‐Trench, Alice S. Whittemore, Paul D.P. Pharoah, Ellen L. Goode, David G. Huntsman, Susan J. Ramus - The Lancet Oncology 2013 被引用: 432

  14. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2018 被引用: 161

  15. Bioavailability and health risk of some potentially toxic elements (Cd, Cu, Pb and Zn) in street dust of Asansol, India

    著者: , , , , - Ecotoxicology and Environmental Safety 2017 被引用: 224

  16. Prognostic gene expression signature for high-grade serous ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sián Fereday, Sue Moore, Jillian A. Hung, K.R. Harrap, T. Sadkowsky, Nirmala Pandeya, M. Malt, Anne Mellon, R. Paul Robertson, T. Vanden Bergh, Marsha Jones, P. Mackenzie, J. Maidens, K. Nattress, Yoke-Eng Chiew, Annie Stenlake, Harold C. Sullivan, B. Alexander, P. Ashover, Scott D. Brown, T. Corrish, L. Green, L. M. Jackman, Kaltin Ferguson, Karla Martin, A. Martyn, B. Ranieri, Jeff White, V. Jayde, Pamela Mamers, Leanne Bowes, Laura Galletta, Daniel A. Giles, Joy Hendley, Kathryn Alsop, Tannin A. Schmidt, H. Shirley, Colleen T. Ball, Christian D. Young, S. Viduka, Hoa Tran, Sanela Bilic, Lydia Glavinas, Julia Brooks, R. Stuart‐Harris, Fred Kirsten, J Rutovitz, P. Clingan, Akisha Glasgow, Anthony Proietto, Stephen Braye, Geoffrey Otton, Jenny Shannon, Tony Bonaventura, Jocelyn M. Stewart, Stephen Begbie, Michael Friedländer, Dany Bell, Sally Baron‐Hay, A. Ferrier, G. Gard, David Nevell, Nick Pavlakis, Susan Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, Neville F. Hacker, Donald E. Marsden ほか 180 名 - Annals of Oncology 2020 被引用: 173

  17. EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2017 被引用: 90

  18. Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2009 被引用: 305

  19. IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2011 被引用: 261

  20. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma

    著者: , , , , , , , , , , , - Cancer Research 2017 被引用: 132

  21. Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2013 被引用: 118

  22. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregg Nelson, Praful Ghatage, Aleksandra Gentry‐Maharaj, Simon A. Gayther, Elizabeth Benjamin, Martin Widschwendter, Maria P. Intermaggio, Barry P. Rosen, Marcus Q. Bernardini, Helen Mackay, Amit M. Oza, Patricia Shaw, Mercedes Jimenez‐Liñan, K E Driver, Jennifer Alsop, Marie Mack, Jennifer M. Koziak, Helen Steed, Carol A. Ewanowich, Anna DeFazio, Georgia Chenevix‐Trench, Sián Fereday, Bo Gao, Sharon E. Johnatty, Joshy George, Laura Galletta, Ellen L. Goode, Susanne K. Kjær, David G. Huntsman, Peter A. Fasching, Kirsten B. Moysich, James D. Brenton, Linda E. Kelemen - British Journal of Cancer 2014 被引用: 110

  23. Synthetic lethality between CCNE1 amplification and loss of BRCA1

    著者: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 被引用: 227

  24. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight

    著者: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 被引用: 115